News

The FDA has cleared Bristol Myers Squibb’s new schizophrenia drug, Cobenfy. This was to be the very first completely new treatment for the chronic mental

A new report declares that by 2050, short-sightedness in children is projected to double as new research finds. According to a new review of more

A major step toward closing the gender gap in stroke care has been taken-with $5 million over five years for the StrokeGoRed project led by

FIFA, in collaboration with the World Health Organization (WHO), launched the world’s biggest concussion awareness campaign named *Suspect and Protect: No Match is Worth the

Pfizer Inc. experimental medication, ponsegromab, has shown promise in the treatment of cancer cachexia, a potentially debilitating condition marked by severe appetite loss and wasting

Pharmaceutical giants are ramping up major investments in targeted radiation therapy, one of the more promising hopefuls for cancer treatment. Companies including Bristol Myers Squibb,

A significant portion of privately insured Americans could be eligible for GLP-1 medications, such as Novo Nordisk’s Wegovy and Ozempic, according to a new analysis

WHO Director-General Dr. Tedros Adhanom Ghebreyesus and Regional Director Dr. Hanan Balkhy have concluded a two-day mission to Port Sudan, reaffirming WHO’s commitment to addressing

Abbott announced on Thursday the launch of its over-the-counter continuous glucose monitor (CGM), Lingo, now available in the U.S. starting at $49. Lingo is designed

The World Health Organization (WHO), with the support of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), has launched a global framework